Table 1. Subject characteristics (N = 10).
| Before | After | P-value | |
|---|---|---|---|
| Age (yr) | 47.4 ± 12.0 | 47.7 ± 12.0 | 0.081 |
| BMI (kg/m2) | 30.2 ± 7.0 | 30.1 ± 6.6 | 0.917 |
| Body mass (kg) | 82.3 ± 15.1 | 83.5 ± 17.3 | 0.340 |
| Body fat (%) | 33.8 ± 10.8 | 33.9 ± 8.5 | 0.920 |
| Fat mass (kg) | 27.7 ± 10.5 | 29.5 ± 11.8 | 0.024 * |
| Fat free mass (kg) | 52.9 ± 7.5 | 52.5 ± 7.8 | 0.623 |
| Free T4 (Umol/l) | 5.6 ± 6.9 | 23.1 ± 3.9 | < 0.001 ** |
| TSH (Umol/l) | 107.6 ± 55.9 | 0.5 ± 0.6 | < 0.001 ** |
| Levothyroxin dose (μg/day) | 0 | 137.75 ± 19.75 |
Subject characteristics in ten patients (two male, eight female) with measurements in the hypothyroid and euthyroid phase of thyroid carcinoma treatment. BMI indicates Body Mass Index. Values are expressed as means ± SD.
* P < 0.05;
** P < 0.01.